GENETIC PREDISPOSITION TO ISCHEMIC HEART DISEASE
暂无分享,去创建一个
F. Fedele | M. Mancone | P. Severino | A. D’Amato | M. Pucci | L. Netti | Mariateresa Pucci | Lucrezia Netti
[1] Maria Laura De Marchis,et al. Diabetes Mellitus and Ischemic Heart Disease: The Role of Ion Channels , 2018, International journal of molecular sciences.
[2] Zhi Li,et al. Effect of AMP‐activated protein kinase subunit alpha 2 (PRKAA2) genetic polymorphisms on susceptibility to type 2 diabetes mellitus and diabetic nephropathy in a Chinese population , 2018, Journal of diabetes.
[3] Pål Aukrust,et al. Increased Levels of Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor‐1 in Ischemic Stroke and Transient Ischemic Attack , 2018, Journal of the American Heart Association.
[4] R. Fisberg,et al. Influence of IL1B, IL6 and IL10 gene variants and plasma fatty acid interaction on metabolic syndrome risk in a cross-sectional population-based study. , 2017, Clinical nutrition.
[5] Z. Wang,et al. Relationship between inducible NOS single-nucleotide polymorphisms and hypertension in Han Chinese , 2018, Herz.
[6] H. Deng,et al. Novel common variants associated with body mass index and coronary artery disease detected using a pleiotropic cFDR method. , 2017, Journal of molecular and cellular cardiology.
[7] T. Henle,et al. Lectin-like oxidized low-density lipoprotein receptor-1 promotes endothelial dysfunction in LDL receptor knockout background. , 2017, Atherosclerosis. Supplements.
[8] A genomic exploration identifies mechanisms that may explain adverse cardiovascular effects of COX-2 inhibitors , 2017, Scientific Reports.
[9] M. Banach,et al. The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction , 2017, Scientific Reports.
[10] J. A. Thompson,et al. Genetic Deletion of NADPH Oxidase 1 Rescues Microvascular Function in Mice With Metabolic Disease , 2017, Circulation research.
[11] Xinchun Yang,et al. The association of eight potentially functional polymorphisms in five adrenergic receptor-encoding genes with myocardial infarction risk in Han Chinese. , 2017, Gene.
[12] Ruyao Wang,et al. Microsatellite and Single Nucleotide Polymorphisms in the Insulin-Like Growth Factor 1 Promoter with Insulin Sensitivity and Insulin Secretion , 2017, Medical science monitor : international medical journal of experimental and clinical research.
[13] Jesse M. Engreitz,et al. A Genetic Variant Associated with Five Vascular Diseases Is a Distal Regulator of Endothelin-1 Gene Expression , 2017, Cell.
[14] Stephen Burgess,et al. Association of Genetic Variants Related to Serum Calcium Levels With Coronary Artery Disease and Myocardial Infarction , 2017, JAMA.
[15] Chen Wang,et al. Polymorphism in ERCC1 confers susceptibility of coronary artery disease and severity of coronary artery atherosclerosis in a Chinese Han population , 2017, Scientific Reports.
[16] Qingxiao Fang,et al. The Gas6 gene rs8191974 and Ap3s2 gene rs2028299 are associated with type 2 diabetes in the northern Chinese Han population. , 2017, Acta biochimica Polonica.
[17] S. Humphries,et al. Effect of Coronary Artery Disease risk SNPs on serum cytokine levels and cytokine imbalance in Premature Coronary Artery Disease. , 2017, Cytokine.
[18] Xiang-Yang Zhang,et al. Myeloperoxidase polymorphism and coronary artery disease risk , 2017, Medicine.
[19] Kristin G Ardlie,et al. Genetic Analysis in UK Biobank Links Insulin Resistance and Transendothelial Migration Pathways to Coronary Artery Disease , 2017, Nature Genetics.
[20] Ping Yang,et al. Association of single nucleotide polymorphisms in the 5′ upstream region of the C4BPA gene with essential hypertension in a northeastern Han Chinese population , 2017, Molecular medicine reports.
[21] Yufeng Yao,et al. The association of six single nucleotide polymorphisms and their haplotypes in CDH13 with T2DM in a Han Chinese population , 2017, Medicine.
[22] R. D. Rudic,et al. Role of Adipose Tissue Endothelial ADAM17 in Age-Related Coronary Microvascular Dysfunction , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[23] S. Harrap,et al. Familial Analysis of Epistatic and Sex-Dependent Association of Genes of the Renin–Angiotensin–Aldosterone System and Blood Pressure , 2017, Circulation. Cardiovascular genetics.
[24] C. Xiao,et al. Association of CYP17A1 Genetic Polymorphisms and Susceptibility to Essential Hypertension in the Southwest Han Chinese Population , 2017, Medical science monitor : international medical journal of experimental and clinical research.
[25] S. Tang,et al. Associations of CYP4A11 gene–gene and gene–smoking interactions with essential hypertension in the male eastern Chinese Han population , 2017, Clinical and experimental hypertension.
[26] Andrew D. Johnson,et al. Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms , 2017, Nature Genetics.
[27] H. Baqai,et al. The communal relation of MTHFR, MTR, ACE gene polymorphisms and hyperhomocysteinemia as conceivable risk of coronary artery disease. , 2017, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.
[28] V. Stepanov,et al. The contribution of CYP2C gene subfamily involved in epoxygenase pathway of arachidonic acids metabolism to hypertension susceptibility in Russian population , 2017, Clinical and experimental hypertension.
[29] Vahagn Ohanyan,et al. Kv1.3 channels facilitate the connection between metabolism and blood flow in the heart , 2017, Microcirculation.
[30] Xiaofeng Zhu,et al. Single-trait and multi-trait genome-wide association analyses identify novel loci for blood pressure in African-ancestry populations , 2017, PLoS genetics.
[31] Y. Fujiwara,et al. Identification of polymorphisms in 12q24.1, ACAD10, and BRAP as novel genetic determinants of blood pressure in Japanese by exome-wide association studies , 2017, Oncotarget.
[32] Y. Izumiya,et al. CYP2C19 variants and epoxyeicosatrienoic acids in patients with microvascular angina , 2017, International journal of cardiology. Heart & vasculature.
[33] V. Lánská,et al. Polygenic hypercholesterolemia: examples of GWAS results and their replication in the Czech-Slavonic population. , 2017, Physiological research.
[34] Z. Rancic,et al. Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evaluation of the novel radiotracer [11C]RS-016 targeting CB2 in atherosclerosis. , 2017, Nuclear medicine and biology.
[35] Yujing Li,et al. Genetic association analysis of polymorphisms in PSD3 gene with obesity, type 2 diabetes, and HDL cholesterol. , 2017, Diabetes research and clinical practice.
[36] K. Lunetta,et al. A novel TCF7L2 type 2 diabetes SNP identified from fine mapping in African American women , 2017, PloS one.
[37] G. Paré,et al. The 9p21.3 locus and cardiovascular risk in familial hypercholesterolemia. , 2017, Journal of clinical lipidology.
[38] He Zhang,et al. Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease , 2017, Journal of the American College of Cardiology.
[39] V. Sandrim,et al. IL-6, TNF-α, and IL-10 levels/polymorphisms and their association with type 2 diabetes mellitus and obesity in Brazilian individuals , 2017, Archives of endocrinology and metabolism.
[40] Sex Differences of the Natriuretic Peptide Polymorphism Associated With Angiographic Coronary Atherosclerosis , 2017, Cardiology research.
[41] I. Drenjančević,et al. Coronary microvascular dysfunction in diabetes mellitus , 2017, The Journal of international medical research.
[42] Y. Nishijima,et al. Contribution of KV1.5 Channel to Hydrogen Peroxide–Induced Human Arteriolar Dilation and Its Modulation by Coronary Artery Disease , 2016, Circulation research.
[43] P. Nihoyannopoulos,et al. The -174 G>C Interleukin-6 Gene Polymorphism is Associated with Angiographic Progression of Coronary Artery Disease over a 4-Year Period. , 2017, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.
[44] A. Momin,et al. Association of Single Nucleotide Polymorphisms of Adiponectin Gene with Type 2 Diabetes Mellitus, and Their Influence on Cardiovascular Risk Markers , 2017, Indian Journal of Clinical Biochemistry.
[45] M. Habib,et al. Association of endothelial nitric oxide synthase (eNOS) gene G894T polymorphism with hypertension risk and complications , 2016, Molecular and Cellular Biochemistry.
[46] A. Dirican,et al. Polymorphisms in the long non-coding RNA CDKN2B-AS1 may contribute to higher systolic blood pressure levels in hypertensive patients. , 2016, Clinical biochemistry.
[47] K. Sakamoto,et al. Sex differences in the impact of CYP2C19 polymorphisms and low-grade inflammation on coronary microvascular disorder. , 2016, American journal of physiology. Heart and circulatory physiology.
[48] Jiantao Song,et al. Association of Genetic Polymorphisms on VEGFA and VEGFR2 With Risk of Coronary Heart Disease , 2016, Medicine.
[49] M. Pirinen,et al. The Contribution of GWAS Loci in Familial Dyslipidemias , 2016, PLoS genetics.
[50] Y. Deshaies,et al. A CpG-SNP Located within the ARPC3 Gene Promoter Is Associated with Hypertriglyceridemia in Severely Obese Patients , 2016, Annals of Nutrition and Metabolism.
[51] Y. Bossé,et al. Epigenetic and genetic variations at the TNNT1 gene locus are associated with HDL-C levels and coronary artery disease. , 2016, Epigenomics.
[52] Yeong-Renn Chen,et al. Differential regulation of TRPV1 channels by H2O2: implications for diabetic microvascular dysfunction , 2016, Basic Research in Cardiology.
[53] Ruth McPherson,et al. Genetics of Coronary Artery Disease. , 2016, Circulation research.
[54] A. Geurts,et al. The NRF2 knockout rat: a new animal model to study endothelial dysfunction, oxidant stress, and microvascular rarefaction. , 2016, American journal of physiology. Heart and circulatory physiology.
[55] Dongming Zhang,et al. Association of Genetic Polymorphisms on Vascular Endothelial Growth Factor and its Receptor Genes with Susceptibility to Coronary Heart Disease , 2016, Medical science monitor : international medical journal of experimental and clinical research.
[56] Huiping Zhang,et al. Association of NCOA3 polymorphisms with Dyslipidemia in the Chinese Han population , 2015, Lipids in Health and Disease.
[57] Jing He,et al. Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation , 2015, Nature Genetics.
[58] K. Bailey,et al. Design of a randomized controlled trial of disclosing genomic risk of coronary heart disease: the Myocardial Infarction Genes (MI-GENES) study , 2015, BMC Medical Genomics.
[59] M. Endres,et al. Modifiable cardiovascular risk factors in adults aged 40–79 years in Germany with and without prior coronary heart disease or stroke , 2015, BMC Public Health.
[60] F. Romeo,et al. Oxidized LDL attenuates protective autophagy and induces apoptotic cell death of endothelial cells: Role of oxidative stress and LOX-1 receptor expression. , 2015, International journal of cardiology.
[61] P. Libby,et al. Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. , 2015, European heart journal.
[62] T. Beaty,et al. Both rare and common variants in PCSK9 influence plasma low-density lipoprotein cholesterol level in American Indians. , 2015, Journal of Clinical Endocrinology and Metabolism.
[63] J. Leopold. Microvascular dysfunction: genetic polymorphisms suggest sex-specific differences in disease phenotype. , 2014, Coronary artery disease.
[64] J. Cunningham,et al. Single nucleotide polymorphisms associated with abnormal coronary microvascular function , 2014, Coronary artery disease.
[65] Yunchao Su,et al. Increasing Muscle Mass Improves Vascular Function in Obese (db/db) Mice , 2014, Journal of the American Heart Association.
[66] B. Saffari,et al. Non-modifiable Factors of Coronary Artery Stenosis in Late Onset Patients with Coronary Artery Disease in Southern Iranian Population , 2014, Journal of cardiovascular and thoracic research.
[67] C. Sena,et al. Endothelial dysfunction - a major mediator of diabetic vascular disease. , 2013, Biochimica et biophysica acta.
[68] R. Leis,et al. Influence of FTO variants on obesity, inflammation and cardiovascular disease risk biomarkers in Spanish children: a case–control multicentre study , 2013, BMC Medical Genetics.
[69] F. Fedele,et al. Role of ion channels in coronary microcirculation: a review of the literature. , 2013, Future cardiology.
[70] Peter Scarborough,et al. Cardiovascular disease in Europe: epidemiological update. , 2014, European heart journal.
[71] F. Fedele,et al. Role of genetic polymorphisms of ion channels in the pathophysiology of coronary microvascular dysfunction and ischemic heart disease , 2013, Basic Research in Cardiology.
[72] T. Villarreal-Molina,et al. Single Nucleotide Polymorphisms within LIPA (Lysosomal Acid Lipase A) Gene Are Associated with Susceptibility to Premature Coronary Artery Disease. A Replication in the Genetic of Atherosclerotic Disease (GEA) Mexican Study , 2013, PloS one.
[73] M. Eren,et al. Evaluation of coronary microvascular function and nitric oxide synthase intron 4a/b polymorphism in patients with coronary slow flow , 2013, Coronary artery disease.
[74] W. Shen,et al. Phosphodiesterase Type 3A Regulates Basal Myocardial Contractility Through Interacting With Sarcoplasmic Reticulum Calcium ATPase Type 2a Signaling Complexes in Mouse Heart , 2013, Circulation research.
[75] W. Chung,et al. A novel channelopathy in pulmonary arterial hypertension. , 2013, The New England journal of medicine.
[76] A. Stewart,et al. Genetics of Coronary Artery Disease in the 21st Century , 2012, Clinical cardiology.
[77] L. Shaw,et al. Myocardial Ischemia in Women: Lessons From the NHLBI WISE Study , 2012, Clinical cardiology.
[78] F. Hu,et al. Genetic susceptibility to coronary heart disease in type 2 diabetes: 3 independent studies. , 2011, Journal of the American College of Cardiology.
[79] M. Ackerman,et al. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations. , 2011, Journal of the American College of Cardiology.
[80] B. Gao,et al. Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. , 2011, Molecular aspects of medicine.
[81] T. Isbir,et al. Cox-2 gene polymorphism and IL-6 levels in coronary artery disease. , 2011, Genetics and molecular research : GMR.
[82] M. Nothnagel,et al. CDKN2BAS is associated with periodontitis in different European populations and is activated by bacterial infection , 2010, Journal of Medical Genetics.
[83] Susan R. Heckbert,et al. Four Novel Loci (19q13, 6q24, 12q24, and 5q14) Influence the Microcirculation In Vivo , 2010, PLoS genetics.
[84] M. Gooz. ADAM-17: the enzyme that does it all , 2010, Critical reviews in biochemistry and molecular biology.
[85] J. M. Lynch,et al. PKC‐permitted elevation of sarcolemmal KATP concentration may explain female‐specific resistance to myocardial infarction , 2009, The Journal of physiology.
[86] Nikolai Petrovsky,et al. Common sequence variation in the VEGFA gene predicts risk of diabetic retinopathy. , 2009, Investigative ophthalmology & visual science.
[87] M. Sturek,et al. Impaired function of coronary BK(Ca) channels in metabolic syndrome. , 2009, American journal of physiology. Heart and circulatory physiology.
[88] Diana C. Chong,et al. Rasip1 is required for endothelial cell motility, angiogenesis and vessel formation. , 2009, Developmental biology.
[89] M. Yacoub,et al. Developmental origins of hypertrophic cardiomyopathy phenotypes: a unifying hypothesis , 2009, Nature Reviews Cardiology.
[90] T. Lumley,et al. Gene Variants Associated With Ischemic Stroke: The Cardiovascular Health Study , 2009, Stroke.
[91] Rachael,et al. Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy. , 2008, Mayo Clinic proceedings.
[92] G. King,et al. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes , 2007, Nature Clinical Practice Endocrinology &Metabolism.
[93] K. Sunagawa,et al. Vasospastic angina and microvascular angina are differentially influenced by PON1 A632G polymorphism in the Japanese. , 2005, Circulation journal : official journal of the Japanese Circulation Society.
[94] A. Fowler,et al. HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. , 2005, American journal of physiology. Heart and circulatory physiology.
[95] S. Gupte,et al. Oxidant and redox signaling in vascular oxygen sensing mechanisms: basic concepts, current controversies, and potential importance of cytosolic NADPH. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[96] C. Stehouwer,et al. Endothelial Dysfunction, Cellular Adhesion Molecules and the Metabolic Syndrome , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[97] H. Drexler,et al. Endothelial function: a critical determinant in atherosclerosis? , 2004, Circulation.
[98] S. Blankenberg,et al. Adhesion molecules and atherosclerosis. , 2003, Atherosclerosis.
[99] D. Kereiakes,et al. Endothelial dysfunction. , 2003, Circulation.
[100] D. Collen,et al. Differential expression of plasminogen activator inhibitor-1, tumor necrosis factor-alpha, TNF-alpha converting enzyme and ADAMTS family members in murine fat territories. , 2003, Biochimica et biophysica acta.
[101] P. Libby. Inflammation in atherosclerosis , 2002, Nature.
[102] Y. Ueki,et al. Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[103] D. Harrison,et al. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. , 2000, Circulation research.
[104] R. de Caterina. Endothelial dysfunctions: common denominators in vascular disease. , 2000, Current opinion in lipidology.
[105] J. Loscalzo,et al. Cellular adhesion molecules and atherogenesis. , 1999, The American journal of medicine.
[106] K. Williams,et al. Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.
[107] A. Yeung,et al. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. , 1995, The New England journal of medicine.